At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 76 enrolled
Drug / intervention
Proton radiation therapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase I/II Study of Proton Beam Therapy for Hepatocellular Carcinoma
In Brief
A Phase 2 clinical trial evaluating Proton radiation therapy for Liver Cancer and Hepatocellular Carcinoma. Completed, enrolled 76 participants across 1 site.
Detailed Summary
This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLiver Cancer, Hepatocellular Carcinoma
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 1998
First PostedFeb 2008
Primary CompletionFeb 2009
TodayJul 2026
First PostedFeb 13, 2008
Enrollment StartMay 1, 1998
Primary CompletionFeb 1, 2009
TodayJul 2, 2026
Enrollment to primary: 10.8 yearsPosted 18.4 years ago
Interventions
Proton radiation therapyradiation
A total dose of 63 Gy will be delivered in 15 equally divided daily fractions over a 3 week coarse as an out-patient.